Our clinical trials program, through national and international academic and industrial partnerships, advances these imaging technologies to pivotal randomized trials in order to achieve regulatory approvals and commercialization.

The DaCosta lab has completed over six PI-sponsored medical device clinical trials at UHN and collaborating centers across the Greater Toronto Area. From first-in-human prototype testing, to interventional device trials, our multidisciplinary team has extensive experience moving new devices from our translation research team through clinical testing across multiple indications with a focus on oncology and diabetic wound healing.